For the quarter ending 2026-03-31, BCAX has $553,599K in assets. $39,641K in debts. $323,462K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 323,462 | 96,685 | 171,673 | 436,606 |
| Prepaid expenses and other assets | 5,162 | 7,252 | 7,205 | 7,785 |
| Marketable securities | 216,291 | 318,116 | 118,494 | - |
| Total current assets | 544,915 | 422,053 | 297,372 | 444,391 |
| Property and equipment, net | 346 | 330 | 135 | 117 |
| Right of use asset operating lease | 1,428 | 1,701 | 1,969 | 2,237 |
| Long term investments | - | - | 117,417 | - |
| Other assets | 6,910 | 6,910 | 7,795 | 6,842 |
| Total assets | 553,599 | 430,994 | 424,688 | 453,587 |
| Accounts payable-Nonrelated Party | 6,188 | 5,515 | 3,003 | 2,041 |
| Accounts payable-Related Party | 1,252 | 2,278 | 659 | 870 |
| Accrued expenses and other current liabilities-Nonrelated Party | 29,948 | 18,898 | 14,986 | 12,000 |
| Accrued expenses and other current liabilities-Related Party | 812 | 1,141 | 1,285 | 1,242 |
| Operating lease liability current portion | 1,140 | 1,117 | 1,095 | 1,074 |
| Total current liabilities | 39,340 | 28,949 | 21,028 | 17,227 |
| Operating lease liability net of current portion | 301 | 593 | 880 | 1,164 |
| Total liabilities | 39,641 | 29,542 | 21,908 | 18,391 |
| Common stock, 0.0001 par value, 500,000,000 and 500,000,000 shares authorized 65,547,037 and 56,600,724 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively | 8 | 7 | 7 | 7 |
| Additional paid-in capital | 929,370 | 760,168 | 724,489 | 720,439 |
| Accumulated other comprehensive (loss) income | -243 | 243 | -136 | - |
| Accumulated deficit | -415,177 | -358,966 | -321,580 | -285,250 |
| Total stockholders' equity | 513,958 | 401,452 | 402,780 | 435,196 |
| Total liabilities and stockholders equity | 553,599 | 430,994 | 424,688 | 453,587 |
Bicara Therapeutics Inc. (BCAX)
Bicara Therapeutics Inc. (BCAX)